|
Morgan Jr, Robert J; Leong, Lucille; Chow, Warren et al. (2012) Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study. Invest New Drugs 30:723-8
|
|
Morgan Jr, R J; Synold, T W; Gandara, D et al. (2007) Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial. Int J Gynecol Cancer 17:373-8
|
|
Lara Jr, Primo N; Law, Lisa Y; Wright, John J et al. (2005) Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial. Anticancer Drugs 16:317-21
|
|
Openshaw, Harry; Beamon, Karen; Longmate, Jeffrey et al. (2005) The effect of height on paclitaxel nerve damage. J Neurooncol 74:207-10
|
|
Lara Jr, Primo N; Mack, Philip C; Synold, Timothy et al. (2005) The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trial. Clin Cancer Res 11:4444-50
|
|
Morgan Jr, Robert J; Synold, Timothy W; Gandara, David et al. (2004) Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer. Cancer Chemother Pharmacol 54:283-9
|
|
Openshaw, Harry; Beamon, Karen; Synold, Timothy W et al. (2004) Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine. Clin Cancer Res 10:461-7
|
|
Lara Jr, Primo N; Chee, Karen Giselle; Longmate, Jeff et al. (2004) Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial. Cancer 100:2125-31
|
|
Lara Jr, Primo N; Gumerlock, Paul H; Mack, Philip C et al. (2004) Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trial. Clin Lung Cancer 6:102-7
|
|
Mack, Philip C; Gandara, David R; Lau, Alvin H et al. (2003) Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma. Cancer Chemother Pharmacol 51:337-48
|
Showing the most recent 10 out of 34 publications
